Bellerophon Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Bellerophon Therapeutics

14/11/2022 16:56

* Bellerophon Therapeutics Inc  BLPH.OQ  reported a
quarterly
adjusted loss of 53 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 58 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bellerophon Therapeutics Inc's reported EPS for the
quarter was
a loss of 53 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bellerophon Therapeutics Inc shares had risen by 0.9% this
quarter and lost 64.5% so far this year.
    * The company reported a quarterly loss of $5.07 million.
    * Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $24.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 04:56 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.58          -0.53          Beat
 Jun. 30 2022      -0.60          -0.43          Beat
 Mar. 31 2022      -0.54          -0.59          Missed
 Dec. 31 2021      -0.60          -0.45          Beat